Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11
pubmed:dateCreated
2006-5-19
pubmed:abstractText
The oncofetal Ag immature laminin receptor (OFA-iLR) is a potential target molecule for immunotherapeutic studies in several tumor entities, including hematological malignancies. In the present study, we characterize two HLA-A*0201-presented epitopes eliciting strong OFA-iLR peptide-specific human cytotoxic T cell (CTLs) responses in vitro. Both allogeneic HLA-A*0201-matched and autologous CTLs recognized and killed endogenously OFA-iLR-expressing tumor cell lines and primary malignant cells from patients with hemopoietic malignancies in an MHC-restricted fashion but spared nonmalignant hemopoietic cells. Spontaneous OFA-iLR peptide-specific T cell reactivity was detectable in a significant proportion of leukemia patients. Interestingly, in patients with chronic lymphocytic leukemia and multiple myeloma but not in those with acute myeloid leukemia, significant frequencies of OFA peptide-specific CTLs could be detected in an early stage of disease but disappeared in patients with progressive disease. The identification of OFA-iLR-derived peptide epitopes provides a basis for tumor immunological studies and therapeutic vaccination strategies in patients with OFA-iLR-expressing malignancies.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0022-1767
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
176
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
6935-44
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:16709854-Adult, pubmed-meshheading:16709854-Aged, pubmed-meshheading:16709854-Antigen Presentation, pubmed-meshheading:16709854-Antigens, Neoplasm, pubmed-meshheading:16709854-Cytotoxicity, Immunologic, pubmed-meshheading:16709854-Cytotoxicity Tests, Immunologic, pubmed-meshheading:16709854-Dendritic Cells, pubmed-meshheading:16709854-Epitopes, T-Lymphocyte, pubmed-meshheading:16709854-Female, pubmed-meshheading:16709854-HLA-A Antigens, pubmed-meshheading:16709854-HLA-A2 Antigen, pubmed-meshheading:16709854-Humans, pubmed-meshheading:16709854-K562 Cells, pubmed-meshheading:16709854-Leukemia, Lymphocytic, Chronic, B-Cell, pubmed-meshheading:16709854-Leukemia, Myeloid, Acute, pubmed-meshheading:16709854-Male, pubmed-meshheading:16709854-Middle Aged, pubmed-meshheading:16709854-Multiple Myeloma, pubmed-meshheading:16709854-Peptide Fragments, pubmed-meshheading:16709854-Protein Binding, pubmed-meshheading:16709854-Receptors, Laminin, pubmed-meshheading:16709854-Ribosomal Proteins, pubmed-meshheading:16709854-T-Lymphocytes, Cytotoxic, pubmed-meshheading:16709854-Transfection
pubmed:year
2006
pubmed:articleTitle
Identification of HLA-A*0201-presented T cell epitopes derived from the oncofetal antigen-immature laminin receptor protein in patients with hematological malignancies.
pubmed:affiliation
General Hospital St. Georg, Department of Hematology, Hamburg, Germany.
pubmed:publicationType
Journal Article